rheumatoid arthritis
Conditions
Interventions
Western medicine group:Methotrexate 10mg/w, plus etoricoxib 1 tablet/day for analgesia when joint pain is significant
Chinese-Western medicine combined group:Myoskeletal ultrasound-guided mini-needle knife combined with intradermal needling on the basis of western drug therapy
Sponsors
Zhejiang Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Complies with the 2010 ACR/EULAR RA classification standard; ? Patients with DAS28>3.2 and limited joint activity; ? 18-65 years old; ? The patient was informed and agreed to participate in this study.
Exclusion criteria
Exclusion criteria: ?Patients with severe organ disease or mental disease; ? Patients with severe deformity of joints; ? Those who have contraindications to the use of the treatments involved in the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ACR20 improvement rate;ACR50 improvement rate;ACR70 improvement rate;Duration of morning stiffness;Visual analog scoring of joint pain and function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Health Assessment Survey;Clinical disease activity index;Patient's overall assessment of their condition;Physician's overall assessment of the patient's condition;Chinese Medicine Symptom Score;Adverse events and incidence; | — |
Countries
China
Contacts
Public ContactHao Guifeng
Zhejiang Provincial People's Hospital
Outcome results
None listed